2024 ANNUAL REPORT

| 25 | techniques to monitor Cerebral Blood Flow (CBF) in brain injury cases—an area where accurate, real-time data can make a life-saving difference. “Our goal is to develop optical techniques to track the CBF in the ICU continuously and non-invasively, allowing for safer, continuous monitoring,” he says. Looking to the future, Ozana’s lab aims to build neuroimaging systems that achieve the high sensitivity of invasive electrodes but are entirely non-invasive. “There’s a growing interest in invasive BCIs, where electrodes are implanted to read brain signals. But my vision is to achieve high levels of sensitivity without requiring surgery,” he explains. Step by step, his team is moving closer to this goal, making progress in neurofeedback systems and real-time brain monitoring technologies that could transform the way we interact with our brain’s signals. Dr. Ozana’s commitment to advancing neuroimaging exemplifies the spirit of innovation and resilience. His lab’s work in optical and acoustical neuroimaging is paving the way for new medical applications, improving our understanding of the brain, and pushing the frontiers of neuroengineering. Dr. Ozana’s commitment to advancing neuroimaging exemplifies the spirit of innovation and resilience. His lab’s work in optical and acoustical neuroimaging is paving the way for new medical applications, improving our understanding of the brain, and pushing the frontiers of neuroengineering.

RkJQdWJsaXNoZXIy NDU2MA==